Back to trial
Eligibility Pre-Screening
Infusion of donor-derived CMV peptide-specific CTL after allogeneic HSCT
This is a simplified pre-screening tool. Your answers help estimate whether you might qualify, but only the research team can confirm your eligibility. This is not medical advice.
Question 1 of 60%